Expanding role of breast cytopathology as a risk predictor: Commentary

Advances in Anatomic Pathology

Volumn 8, Issue 5, 2001, Pages 255-263

  Masood, Shahla ^a  

^a UNIVERSITY OF FLORIDA HEALTH SCIENCE CENTER   (United States)

Author keywords

Atypical ductal hyperplasia; Breast cancer prevention; Fine needle aspiration biopsy; Risk factors

Indexed keywords

BREAST TUMOR; FEMALE; HUMAN; PATHOLOGY; PREDICTION AND FORECASTING; REVIEW; RISK FACTOR;

BREAST NEOPLASMS; FEMALE; HUMANS; PREDICTIVE VALUE OF TESTS; RISK FACTORS;

EID: 0035464515     PISSN: 10724109     EISSN: 15334031     Source Type: Journal    
DOI: 10.1097/00125480-200109000-00002     Document Type: Note

References (36)

1. Fisher B, Constantine JP, Wickerham DL, et al. Tamoxifen for prevention of Breast Cancer: Report of the National Surgical Adjuvant Breast and Bowel Project P-1 Study. J Natl Cancer Inst 1998;(90):1371-88. (Pubitemid 28439961)
2. Eby N, Chang-Claude J, Bishop DJ. The familial and genetic susceptibility for breast cancer. Cancer Causes Control 1994;5:438-70.
3. Narod SA, Ford DA, Devilee P, et al. An evaluation of genetic heterogeneity in 145 breast-ovarian cancer families. Breast cancer linkage consortium. Am J Hum Genet 1995;36:254-64.
4. Dupont WD, Page DL. Risk factors for breast cancer in women with proliferative breast disease. N Engl J Med 1985;312:146-51. (Pubitemid 15192861)
5. Wanebo HJ, Feldman PS, Wilhelm MC, et al. Fine needle aspiration cytology in lieu of open biopsy in management of primary breast cancer. Ann Surg 1984;199:569-78.
6. Masood S. Cytopathology of the breast. Chicago: ASCP Press, 1995.
7. Masood S, Frykberg ER, McLellan GL, et al. Cytologic differentiation between proliferative and nonproliferative breast disease in mammographically guided fine needle aspirates. Diagn Cytopathol 1991;7:581-90.
8. Marshall CJ, Schumann GB, Ward JH, et al. Cytologic identification of clinically occult proliferative breast disease in women with a family history of breast cancer. Am J Clin Pathol 1991;95:157-65.
9. Fabin CJ, Zalles C, Kamel S, et al. Biomarkers and cytologic abnormalities in women at high and low risk for breast cancer. J Cell Biochem 1993;176:152-60.
10. Masood S, Rasty G. potential value of cytology in the detection of breast cancer precursors by fine needle aspiration biopsy: "the future pap smear for breast cancer." Acta Cytol 1999;43(5):890
11. Khan SA, Masood D, Miller L, et al. random fine needle aspiration of the breast of women at increased risk and standard risk controls. Breast J 1998;4:420-5. (Pubitemid 29018653)
12. Fabian CJ, Kimler BF, Zalles CM, et al. short term breast cancer prediction by random periareolar fine needle aspiration cytology and the gail risk model. J Natl Cancer Inst 2000;92:1217-27. (Pubitemid 30627730)
13. Wrensch M, Petrakis NL, King EB, et al. breast cancer risk associated with abnormal cytology in nipple aspirates of breast fluids and prior history of breast biopsy. Am J Epidemiol 1993;137:829-33. (Pubitemid 23149661)
14. Page DL. Dupont WD, Rogers W, et al. atypical hyperplastic lesions of the female breast, a long-term follow-up study. Cancer 1985;55:2698.
15. Dupont WD, Parl FF, Hartman WH, et al. breast cancer risk associated with proliferative breast disease with atypical hyperplasia. Cancer 1993;71:1258-65. (Pubitemid 23054916)
16. Boone CW, Kelloff G. biomarkers of premalignant breast disease and their use as surrogate endpoints in clinical trials of chemopreventitive agents. Breast J 1995;1:228-35.
17. Fabian C, Kilmer B, Brady D, et al. phase ii chemoprevention trial of dfmo using the random fna model. Breast Cancer Res Treatment 2000;64(1):48.
18. Dizura BR, Bonfiglio TA. needle cytology of the breast. Acta Cytol 1979;23:332-40.
19. Bibbo M, Scheiber M, Cajulius R, et al. stereotaxic fine needle aspiration cytology occult malignant and premalignant breast lesions. Acta Cytol 1988;32:193-201. (Pubitemid 18091148)
20. Masood S, Frykberg ER, McClellan GL, et al. prospective evaluation of radiologically detected fine needle aspiration biopsy of nonpalpable breast lesions. Cancer 1990;66:1480-7. (Pubitemid 20355413)
21. Masood S, Hardy NM, Assof-Munasifi N. cytologic grading system in diagnosis of high-risk and malignant breast lesions: merits and pitfalls. Acta Cytol 1994;38:797-8.
22. Sneige N, Staerkel GA. fine needle aspiration cytology of ductal hyperplasia with and without atypia and ductal carcinoma in situ. Hum Pathol 1994;25:485-92. (Pubitemid 24173865)
23. Abendroth CS, Wang HH, Ducatman BS. comparative features of carcinoma in situ and atypical ductal hyperplasia of the breast on fine needle aspiration biopsy. Am J Clin Pathol 1991;96:654-9.
24. Silverman J, Masood S, Ducatman BS, et al. Can FNA biopsy separate atypical hyperplasia, carcinoma in situ and invasive carcinoma of the breast? Cytomorphic criteria and limitations in diagnosis. Diagn Cytopathology 1993;9:713-28. (Pubitemid 24022658)
25. Sidawy M, Stoler M, Frable W, et al. interobserver variability in the classification of proliferative breast lesions by fine-needle aspiration: results of the papanicolaou society of cytopathology study. Diagn Cytopathol 1998;18(2):150-65. (Pubitemid 28087018)
26. Shiels LA, Mulford D, Dawson AG. cytomorphology of proliferative breast disease. Acta Cytol 1993;37(5):768(12)A.
27. Stanley MA, Henry-Stanley MJ, Zera R. prospective study of highrisk proliferative lesions of breast duct epithelium by fine needle aspiration. Acta Cytol 1991;35(5):611(36)A.
28. Masood S, Lu L, Assaf Munasifi N, et al. application of immunostaining for muscle specific actin for detection of myoepithelial cells in breast fine needle aspirates. Diagn Cytpathol 1995;13:71-4.
29. Masood S, Hardy NM, Assaf N. the value of muscle specific actin immunostaining in differtiation between atypical hyperplasia and carcinoma in breast fine needle aspirates. Acta Cytol 1994;38(5):861(126A).
30. King ER, Chen KL, Duarte L, et al. image cytometric classification of premalignant breast disease in fine-needle aspirates. Cancer 1998;62:114-24.
31. King ER, Chen KL. Hem JD, et al. characterization of image cytometry of ductal epithelial proliferative disease of the breast. Mod Pathol 1991;4:291-6.
32. Dershaw DD, Morris EA, Liberman L, et al. nondiagnostic stereotaxic core breast biopsy: results of rebiopsy. Radiology 1996;198(2):313-5.
33. Rosai J. Borderline epithelial lesions of the breast. Am J Surg Path 1991;15:209-21.
34. Schnitt SJ, Connoly JL, Tavassoli FA, et al. interobserver reproducibility in the diagnosis of ductal proliferative breast lesions using standard criteria. Am J Surg Path 1992;16:1133-43. (Pubitemid 23004420)
35. The uniform approach to breast fine needle aspiration biopsy. Breast J 1997;3:149-68.
36. Masood S. Diagnostic terminology in breast fine needle aspiration biopsy: redefining the term atypia cancer. Cytopathology 1999;87 (1):1-4. (Pubitemid 29104346)